DEL phenotype.

Dong H Kwon, S G Sandler, Willy A Flegel
Author Information
  1. Dong H Kwon: Department of Pathology and Laboratory Medicine, MedStar Georgetown University Hospital.
  2. S G Sandler: Professor of Pathology and Medicine, Georgetown University School of Medicine, and Medical Director, Transfusion Service, Department of Laboratory Medicine, MedStar Georgetown University Hospital.
  3. Willy A Flegel: Chief, Laboratory Services Section, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD, and Professor of Pathology (adjunct), Georgetown University School of Medicine.

Abstract

CONCLUSIONS: DEL red blood cells (RBCs) type as D- by routine serologic methods and are transfused routinely, without being identified as expressing a very weak D antigen, to D- recipients. DEL RBCs are detected only by adsorption and elution of anti-D or by molecular methods. Most DEL phenotypes have been reported in population studies conducted in East Asia, although DEL phenotypes have been detected also among Caucasian individuals. Approximately 98 percent of DEL phenotypes in East Asians are associated with the RHD*DEL1 or RHD*01EL.01 allele. The prevalence of DEL phenotypes has been reported among D- Han Chinese (30%), Japanese (28%), and Korean (17%) populations. The prevalence of DEL phenotypes is significantly lower among D- Caucasian populations (0.1%). Among the 3-5 percent of African individuals who are D-, there are no reports of the DEL phenotype. Case reports from East Asia indicate that transfusion of DEL RBCs to D- recipients has been associated with D alloimmunization. East Asian immigrants constitute 2.1 percent of the 318.9 million persons residing in the United States, and an estimated 2.8 percent are blood donors. Using these statistics, we estimate that 68-683 units of DEL RBCs from donors of East Asian ancestry are transfused as D- annually in the United States. Given the reports from East Asia of D alloimmunization attributed to transfusion of DEL RBCs, one would expect an occasional report of D alloimmunization in the United States following transfusion of DEL RBCs to a D- recipient. If such cases do occur, the most likely reason that they are not detected is the absence of active post-transfusion monitoring for formation of anti-D.

References

  1. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1234-7 [PMID: 17204201]
  2. Transfusion. 1984 Nov-Dec;24(6):542 [PMID: 6438843]
  3. J Lab Clin Med. 2005 Dec;146(6):321-5 [PMID: 16310514]
  4. Transfus Med. 1997 Sep;7(3):227-31 [PMID: 9316224]
  5. Transfusion. 2005 Oct;45(10):1547-51 [PMID: 16181202]
  6. Transfusion. 2005 Oct;45(10):1581-4 [PMID: 16181208]
  7. Korean J Lab Med. 2009 Aug;29(4):361-5 [PMID: 19726900]
  8. Transfusion. 2005 Mar;45(3):345-52 [PMID: 15752151]
  9. J Clin Invest. 1997 Jul 15;100(2):373-9 [PMID: 9218514]
  10. Transfusion. 2008 Nov;48(11):2461-75 [PMID: 19054376]
  11. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Dec;31(6):793-6 [PMID: 25449092]
  12. Blood Transfus. 2014 Apr;12(2):238-43 [PMID: 23399369]
  13. Transfus Med Hemother. 2015 Jan;42(1):15-21 [PMID: 25960711]
  14. N Engl J Med. 2010 Feb 4;362(5):472-3 [PMID: 20130261]
  15. J Zhejiang Univ Sci B. 2012 Nov;13(11):913-8 [PMID: 23125084]
  16. Transfusion. 2012 Sep;52(9):2016-9 [PMID: 22313164]
  17. Transfusion. 2017 May;57(5):1226-1234 [PMID: 28205236]
  18. Am J Clin Pathol. 2004 Aug;122(2):193-8 [PMID: 15323135]
  19. Transfus Med Hemother. 2013 Jun;40(3):172-81 [PMID: 23922542]
  20. Vox Sang. 2015 Nov;109(4):359-65 [PMID: 25953588]
  21. Blood Transfus. 2016 Sep;14 (5):425-33 [PMID: 26710354]
  22. Transfusion. 1993 Apr;33(4):348-51 [PMID: 8480357]
  23. Transfus Med. 2015 Jun;25(3):163-9 [PMID: 26033335]
  24. Transfus Med. 2008 Jun;18(3):199-203 [PMID: 18598284]
  25. Transfus Clin Biol. 2010 Oct;17(4):260-4 [PMID: 20961786]
  26. Transl Res. 2007 Jan;149(1):31-6 [PMID: 17196520]
  27. BMC Genet. 2001;2:10 [PMID: 11495631]
  28. Transfusion. 2017 Jul;57(7):1644-1655 [PMID: 28370164]
  29. Hum Mutat. 2016 Jun;37(6):564-9 [PMID: 26931183]
  30. Blood. 1998 Oct 1;92(7):2602-4 [PMID: 9746809]
  31. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1478-81 [PMID: 23257457]
  32. Transfusion. 1991 Oct;31(8):782 [PMID: 1926326]
  33. Transfus Med Hemother. 2014 Oct;41(5):357-63 [PMID: 25538538]
  34. Transfusion. 2006 Dec;46(12):2128-37 [PMID: 17176325]
  35. Transfusion. 2005 Apr;45(4):520-6 [PMID: 15819672]
  36. Vox Sang. 2002 Aug;83(2):156-61 [PMID: 12201845]
  37. Transfusion. 2007 Aug;47(8):1552-5 [PMID: 17655603]
  38. Ann Clin Lab Sci. 2008 Summer;38(3):258-63 [PMID: 18715855]
  39. Transfusion. 2009 Mar;49(3):465-71 [PMID: 19243542]
  40. BMC Med Genet. 2014 May 05;15:54 [PMID: 24884404]
  41. Transfusion. 2005 Oct;45(10):1561-7 [PMID: 16181205]
  42. Ann Lab Med. 2015 Sep;35(5):554-6 [PMID: 26206698]
  43. Blood. 2002 Jul 1;100(1):306-11 [PMID: 12070041]
  44. Vox Sang. 2016 Nov;111(4):425-430 [PMID: 27864976]
  45. Vox Sang. 2009 Aug;97(2):139-46 [PMID: 19490579]
  46. Chin Med J (Engl). 2012 Sep;125(18):3251-5 [PMID: 22964318]

Grants

  1. Z99 CL999999/Intramural NIH HHS

MeSH Term

Alleles
Blood Donors
Blood Transfusion
Female
Humans
Phenotype
Pregnancy
Rh-Hr Blood-Group System

Chemicals

Rh-Hr Blood-Group System

Word Cloud

Created with Highcharts 10.0.0DELD-RBCsEastphenotypesDpercentdetectedAsiaamongreportstransfusionalloimmunizationUnitedStatesbloodmethodstransfusedrecipientsanti-DreportedCaucasianindividualsassociatedprevalencepopulationsphenotypeAsian2donorsCONCLUSIONS:redcellstyperoutineserologicroutinelywithoutidentifiedexpressingweakantigenadsorptionelutionmolecularpopulationstudiesconductedalthoughalsoApproximately98AsiansRHD*DEL1RHD*01EL01alleleHanChinese30%Japanese28%Korean17%significantlylower01%Among3-5AfricanCaseindicateimmigrantsconstitute13189millionpersonsresidingestimated8Usingstatisticsestimate68-683unitsancestryannuallyGivenattributedoneexpectoccasionalreportfollowingrecipientcasesoccurlikelyreasonabsenceactivepost-transfusionmonitoringformation

Similar Articles

Cited By